Boston University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston University sits in the top decile of US sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count).
Boston University: 185 sponsored US clinical trials, 23 recruiting.
Boston University sponsors 185 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 125 completed. 12 of these trials are in Phase 3-4 (later-stage) and 35 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 3 trials.
Top-decile sponsor footprint
Boston University ranks in the top decile of sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
125 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
185 total, page 1 of 4
Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic
NCT07232641
Self-Help Cognitive Processing Therapy (CPT)/Women Veterans Network (WoVeN) Study
NCT07250061
The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD)
NCT06676098
Measuring Outcomes With Validated Exercise
NCT07270185
Oral Surgery Virtual Reality Glasses Study
NCT06723158
Postural Perturbations Tracing to the Stomatognathic System
NCT06974591
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
NCT07090226
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
NCT06906302
A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Disabilities
NCT06710483
The Role of Vitamin K on Knee Osteoarthritis Outcomes
NCT06385275
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
NCT06757075
Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders
NCT05934305
Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication
NCT06088303
Evaluating Interventions for Intimate Partner Violence Use in Washington State
NCT06526247
Written Exposure Therapy for Suicide Prevention
NCT05878795
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
NCT06088277
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
NCT06168019
Telehealth for Pain and Unhealthy Drinking Among PLWH
NCT05503173
Treatment for Antepartum Posttraumatic Stress Disorder/PTSD Study
NCT05486793
COVID-19 Transmission and Morbidity in Malawi
NCT05973084
Cognitive Processing Therapy (CPT) Memory Support (MS) Study
NCT05310097
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
NCT05381597
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
NCT04468360
A Simple Intervention to Increase Persistence on PrEP in MSM to Improve Decision Making
NCT06476847
Scalable Communication Modalities for Returning Genetic Research Results
NCT04407611
Physical Activity for PLWH and Unhealthy Drinking
NCT05505942
Longitudinal Spatial Frequency Domain Imaging Study
NCT05672992
VR Smoking Cessation During a Dental Hygiene Visit
NCT04524533
A Cluster Randomized Trial of the H2GO! Program
NCT04265794
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
NCT04165564
Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease
NCT03560960
International Bicuspid Aortic Valve Consortium (BAVCon)
NCT01980797
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
NCT02504697
Identification of Genetic Causes of Bicuspid Aortic Valve Disease
NCT01026571
PrEPwise Pilot Among Black Women in Eastern Virginia
NCT07398482
HIV Testing in Community Health Center Dental Clinics
NCT07089849
Online Intervention for Transgender/Nonbinary Young Adults' Experiences With Alcohol and Romantic Relationships
NCT06392542
Cigarillo Warnings Image Sorting Study
NCT05838378
Evaluation of an Artificial Intelligence-Assisted, Image-Based Dietary Assessment Tool in the Framingham Heart Study
NCT06455111
Vaping Prevention and Vaping in Youth (Vapechat)
NCT06003439
Respiratory Microbiota and Immune Response in CVID
NCT06173128
Feasibility of Remote Tai Chi
NCT05693805
Event-Related Potential (ERP) Components in Clinical Diagnosis
NCT05673759
Wrist Cooling for Hot Flashes Clinical Trial
NCT05595213
Clinic-Based Atopic Dermatitis Therapeutic Patient Education
NCT04352270
Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
NCT05200403
The Impact of Cigarillo Warnings on Purchasing
NCT05434013
Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes
NCT05139914
Zambia Infant Cohort Study - Brains Optimized for Surviving and Thriving
NCT05119959
Geriatric Anorexia Study 2.0
NCT05211973
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 16 |
| Phase 3 | 4 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Boston University pipeline
23 recruiting of 185 indexed (12% open); 125 completed (68%).
Phase mix: 12 late (III/IV) vs 35 early (I/II) (early-phase heavy).
Top condition: HIV Infections (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston University: open-pipeline peers nationwide
Peers matched on 185 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Boston University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 185 trials (± recruiting share)
- National Human Genome Research Institute (NHGRI) · 185 trials · 16% recruiting
- Children's Mercy Hospital Kansas City · 184 trials · 11% recruiting
- Arizona State University · 187 trials · 15% recruiting
- Johns Hopkins Bloomberg School of Public Health · 187 trials · 14% recruiting
Sponsors near 12% open enrollment (± trial volume)
- AstraZeneca · 12% recruiting · 1,285 trials
- National Heart, Lung, and Blood Institute (NHLBI) · 12% recruiting · 501 trials
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
Related
What to do with this Boston University page
185 registered trials is a research-attention snapshot, not an endorsement of Boston University or any single study.
- 23 of Boston University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV Infections is the condition Boston University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Boston University pipeline card: 185 registered trials from official public datasets.Report a data error.